Eutecma acquires Tempaid to expand pharma cold chain packaging

USA – Eutecma has acquired Tempaid, a North American provider of temperature-controlled packaging for pharmaceutical, life sciences and healthcare organisations, expanding its cold chain product range.

Following the acquisition, the combined business will provide reusable and single-use packaging, covering individual mailers through to bulk pallet shippers. 

Eutecma, established in 2008, manufactures passive cooling equipment for pharmaceutical supply chains and third-party logistics providers. 

Its products include ICECATCH cooling systems, PROTECT shipping systems and Thermal Covers. 

Tempaid supplies validated thermal packaging products including SpeedyPac mailers, SteadyPac thermal shippers, gel packs and PCM mats for pharmaceutical deliveries. Financial details of the deal were not disclosed.

Leadership Cites Complementary Product Lines

Ryan Sanders, founder of Tempaid, said the company’s growth meant expanding geographically, driving efficiencies and building a comprehensive product line covering the whole cold chain, which prompted the search for the right partners. 

He noted that with Eutecma and the backing of Great Point Partners, the company found a partner whose products began where Tempaid’s ended, with both organisations listening to customers and solving their problems.

Patent Portfolio and Design Expertise Underpin Combination

The companies’ leadership teams include product designers and inventors who jointly hold several thermal packaging patents. Kevin Grogan, chief executive of Eutecma, who took over the position last year, will head the combined company. 

He said Eutecma and Tempaid were uniquely suited to address the demanding needs of the cold chain marketplace. 

He added that the company was committed to preserving the passionate, customer-focused culture of both organisations while accelerating investments in innovation and new product development through the support of strategic partner Great Point Partners, which acquired a majority stake in Eutecma in June 2025.

Customers Retain Access to Both Product Ranges

Customers in the pharmaceutical, diagnostic, life science and biotech sectors will continue to have access to the product and service ranges offered by both companies. 

The acquisition reflects ongoing consolidation in temperature-controlled packaging, where pharmaceutical manufacturers and logistics providers require validated systems capable of maintaining precise temperature ranges from manufacturing through last-mile delivery.

Reusable and single-use formats serve different distribution models, and combining both capabilities positions the merged business to serve customers across clinical trials, commercial distribution and direct-to-patient channels.

Subscribe to our email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE